Development of a type 2 diabetes risk model from a panel of serum biomarkers from the Inter99 cohort.
Development of a type 2 diabetes risk model from a panel of serum biomarkers from the Inter99 cohort.
复制标题
DOI:
10.2337/dc08-1935
复制
发表时间:
2009-07
期刊:
影响因子:
16.2
通讯作者:
Borch-Johnsen K
中科院分区:
文献类型:
--
作者:
Kolberg JA;Jørgensen T;Gerwien RW;Hamren S;McKenna MP;Moler E;Rowe MW;Urdea MS;Xu XM;Hansen T;Pedersen O;Borch-Johnsen K
The purpose of this study was to develop a model for assessing the 5-year risk of developing type 2 diabetes from a panel of 64 circulating candidate biomarkers. Subjects were selected from the Inter99 cohort, a longitudinal population-based study of ∼6,600 Danes in a nested case-control design with the primary outcome of 5-year conversion to type 2 diabetes. Nondiabetic subjects, aged ≥39 years, with BMI ≥25 kg/m2 at baseline were selected. Baseline fasting serum samples from 160 individuals who developed type 2 diabetes and from 472 who did not were tested. An ultrasensitive immunoassay was used to measure of 58 candidate biomarkers in multiple diabetes-associated pathways, along with six routine clinical variables. Statistical learning methods and permutation testing were used to select the most informative biomarkers. Risk model performance was estimated using a validated bootstrap bias-correction procedure. A model using six biomarkers (adiponectin, C-reactive protein, ferritin, interleukin-2 receptor A, glucose, and insulin) was developed for assessing an individual's 5-year risk of developing type 2 diabetes. This model has a bootstrap-estimated area under the curve of 0.76, which is greater than that for A1C, fasting plasma glucose, fasting serum insulin, BMI, sex-adjusted waist circumference, a model using fasting glucose and insulin, and a noninvasive clinical model. A model incorporating six circulating biomarkers provides an objective and quantitative estimate of the 5-year risk of developing type 2 diabetes, performs better than single risk indicators and a noninvasive clinical model, and provides better stratification than fasting plasma glucose alone.
登录
查看更多内容
影响因子:
158.5
作者:
Knowler, WC;Barrett-Connor, E;Nathan, DM
通讯作者:
Nathan, DM
影响因子:
168.9
作者:
Wong, Tien Y.;Liew, Gerald;Shaw, Jonathan
通讯作者:
Shaw, Jonathan
DOI:
10.1016/j.bbrc.2004.01.065
发表时间:
2004-03-05
影响因子:
3.1
作者:
Kitabchi, AE;Stentz, FB;Umpierrez, GE
通讯作者:
Umpierrez, GE
影响因子:
16.2
作者:
Glümer, C;Vistisen, D;Colagiuri, S
通讯作者:
Colagiuri, S
影响因子:
--
作者:
Wilson, Peter W. F.;Meigs, James B.;D'Agostino, Ralph B., Sr.
通讯作者:
D'Agostino, Ralph B., Sr.